Related Experiment Videos

Transgenic mouse model for imaging of ATF4 translational activation-related cellular stress responses in vivo

Takao Iwawaki1,2, Ryoko Akai1,2, Takae Toyoshima2

  • 1Division of Cell Medicine, Department of Life Science, Medical Research Institute, Kanazawa Medical University, 1-1 Daigaku, Uchinada, Kahoku, Ishikawa 920-0293, Japan.

Scientific Reports
|April 8, 2017
PubMed

Insights

Researchers developed a novel transgenic mouse model to track the translational activation of Activating Transcription Factor 4 (ATF4) during cellular stress. This tool aids in studying ATF4

Area of Science:

  • Molecular Biology
  • Cellular Stress Response
  • Biomedical Research

Background:

  • Activating transcription factor 4 (ATF4) is crucial for cellular adaptation to stress.
  • Dysregulation of ATF4 is implicated in various diseases.
  • Understanding ATF4's translational control is vital for physiological and pathological insights.

Purpose of the Study:

  • To develop and validate a transgenic mouse model for monitoring ATF4 translational activation.
  • To assess the model's utility in detecting diverse cellular stress responses.
  • To establish a tool for investigating ATF4's role in health and disease.

Main Methods:

  • Development of a transgenic mouse model with a reporter system.
  • In vitro, ex vivo, and in vivo validation of the reporter system's response to cellular stress.
  • Evaluation of stress intensity and duration-dependent ATF4 activation.

Main Results:

  • The mouse model successfully detected nutrient starvation, antiviral, ER stress, and oxidative stress responses.
  • The reporter system demonstrated stress intensity-dependent activation.
  • The reporter system showed stress duration-dependent activation.

Conclusions:

  • The developed mouse model is effective for imaging ATF4 translational activation across multiple biological scales.
  • This tool facilitates research into the physiological and pathological roles of ATF4-related stress.
  • The model holds potential for developing therapeutic drugs for ATF4-associated diseases.

Related Concept Videos